Annual SG&A:
$488.43M+$81.87M(+20.14%)Summary
- As of today, ACAD annual SG&A is $488.43 million, with the most recent change of +$81.87 million (+20.14%) on December 31, 2024.
 - During the last 3 years, ACAD annual SG&A has risen by +$92.40 million (+23.33%).
 - ACAD annual SG&A is now at all-time high.
 
Performance
ACAD SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$126.37M(-100.00%)Summary
- As of today, ACAD quarterly SG&A is $0.00, with the most recent change of -$126.37 million (-100.00%) on June 30, 2025.
 - Over the past year, ACAD quarterly SG&A has dropped by -$117.06 million (-100.00%).
 - ACAD quarterly SG&A is now -100.00% below its all-time high of $133.29 million, reached on September 30, 2024.
 
Performance
ACAD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$8.90B+$222.16M(+2.44%)Summary
- As of today, ACAD TTM SG&A is -$8.90 billion, with the most recent change of +$222.16 million (+2.44%) on June 30, 2025.
 - Over the past year, ACAD TTM SG&A has dropped by -$9.33 billion (-2147.99%).
 - ACAD TTM SG&A is now -12913.28% below its all-time high of -$68.37 million.
 
Performance
ACAD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
ACAD Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM | 
|---|---|---|---|
| 1Y1 Year | +20.1% | -100.0% | -2148.0% | 
| 3Y3 Years | +23.3% | -100.0% | -2459.8% | 
| 5Y5 Years | +50.0% | -100.0% | -2522.0% | 
ACAD Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +32.3% | -100.0% | at low | at high | +8.6% | 
| 5Y | 5-Year | at high | +50.0% | -100.0% | at low | -22.7% | +8.6% | 
| All-Time | All-Time | at high | >+9999.0% | -100.0% | at low | >-9999.0% | +8.6% | 
ACAD Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2025 | -  | $0.00(-100.0%)  | $259.66M(-31.1%)  | 
| Mar 2025 | -  | $126.37M(>+9900.0%)  | $376.73M(+5.1%)  | 
| Dec 2024 | $488.43M(+20.1%)  | $0.00(-100.0%)  | $358.35M(-23.7%)  | 
| Sep 2024 | -  | $133.29M(+13.9%)  | $469.81M(+8.1%)  | 
| Jun 2024 | -  | $117.06M(+8.4%)  | $434.41M(+5.1%)  | 
| Mar 2024 | -  | $107.99M(-3.1%)  | $413.31M(+1.7%)  | 
| Dec 2023 | $406.56M(+10.2%)  | $111.47M(+13.9%)  | $406.56M(+1.8%)  | 
| Sep 2023 | -  | $97.89M(+2.0%)  | $399.50M(+5.2%)  | 
| Jun 2023 | -  | $95.97M(-5.2%)  | $379.71M(+1.6%)  | 
| Mar 2023 | -  | $101.23M(-3.0%)  | $373.65M(+1.2%)  | 
| Dec 2022 | $369.09M(-6.8%)  | $104.40M(+33.7%)  | $369.09M(-0.4%)  | 
| Sep 2022 | -  | $78.11M(-13.1%)  | $370.46M(-1.7%)  | 
| Jun 2022 | -  | $89.90M(-7.0%)  | $377.01M(-2.5%)  | 
| Mar 2022 | -  | $96.68M(-8.6%)  | $386.58M(-4.3%)  | 
| Dec 2021 | $396.03M(+1.9%)  | $105.77M(+24.9%)  | $404.07M(-3.6%)  | 
| Sep 2021 | -  | $84.66M(-14.9%)  | $419.05M(+0.1%)  | 
| Jun 2021 | -  | $99.47M(-12.9%)  | $418.78M(+3.1%)  | 
| Mar 2021 | -  | $114.17M(-5.5%)  | $406.23M(+2.5%)  | 
| Dec 2020 | $388.66M(+19.4%)  | $120.75M(+43.1%)  | $396.21M(+7.9%)  | 
| Sep 2020 | -  | $84.39M(-2.9%)  | $367.33M(+2.6%)  | 
| Jun 2020 | -  | $86.92M(-16.5%)  | $357.91M(+5.0%)  | 
| Mar 2020 | -  | $104.15M(+13.4%)  | $341.01M(+2.8%)  | 
| Dec 2019 | $325.64M(+22.5%)  | $91.87M(+22.5%)  | $331.58M(+5.1%)  | 
| Sep 2019 | -  | $74.97M(+7.1%)  | $315.55M(+4.1%)  | 
| Jun 2019 | -  | $70.02M(-26.1%)  | $303.20M(-0.3%)  | 
| Mar 2019 | -  | $94.72M(+24.9%)  | $304.17M(+11.9%)  | 
| Dec 2018 | $265.76M(+4.2%)  | $75.84M(+21.1%)  | $271.71M(+3.5%)  | 
| Sep 2018 | -  | $62.63M(-11.8%)  | $262.56M(+0.1%)  | 
| Jun 2018 | -  | $70.99M(+14.0%)  | $262.19M(+3.5%)  | 
| Mar 2018 | -  | $62.26M(-6.6%)  | $253.31M(-1.4%)  | 
| Dec 2017 | $255.06M(+36.8%)  | $66.69M(+7.1%)  | $256.80M(+3.6%)  | 
| Sep 2017 | -  | $62.26M(+0.2%)  | $247.77M(+5.0%)  | 
| Jun 2017 | -  | $62.11M(-5.5%)  | $236.05M(+5.0%)  | 
| Mar 2017 | -  | $65.75M(+14.0%)  | $224.71M(+20.5%)  | 
| Dec 2016 | $186.46M(+111.2%)  | $57.66M(+14.1%)  | $186.46M(+23.1%)  | 
| Sep 2016 | -  | $50.53M(-0.5%)  | $151.41M(+24.9%)  | 
| Jun 2016 | -  | $50.77M(+84.7%)  | $121.18M(+32.4%)  | 
| Mar 2016 | -  | $27.49M(+21.6%)  | $91.53M(+3.7%)  | 
| Dec 2015 | $88.30M(+169.6%)  | $22.62M(+11.4%)  | $88.30M(+16.0%)  | 
| Sep 2015 | -  | $20.31M(-3.8%)  | $76.11M(+19.2%)  | 
| Jun 2015 | -  | $21.12M(-13.0%)  | $63.86M(+26.0%)  | 
| Mar 2015 | -  | $24.26M(+132.8%)  | $50.69M(+54.8%)  | 
| Dec 2014 | $32.75M(+157.5%)  | $10.42M(+29.3%)  | $32.75M(+23.1%)  | 
| Sep 2014 | -  | $8.06M(+1.3%)  | $26.61M(+19.1%)  | 
| Jun 2014 | -  | $7.95M(+25.8%)  | $22.34M(+32.3%)  | 
| Mar 2014 | -  | $6.32M(+47.8%)  | $16.89M(+32.8%)  | 
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Dec 2013 | $12.72M(+81.7%)  | $4.28M(+12.6%)  | $12.72M(+18.4%)  | 
| Sep 2013 | -  | $3.80M(+52.1%)  | $10.74M(+27.4%)  | 
| Jun 2013 | -  | $2.50M(+16.0%)  | $8.43M(+12.6%)  | 
| Mar 2013 | -  | $2.15M(-6.4%)  | $7.49M(+7.0%)  | 
| Dec 2012 | $7.00M(-8.0%)  | $2.30M(+54.7%)  | $7.00M(+13.3%)  | 
| Sep 2012 | -  | $1.49M(-4.6%)  | $6.18M(-0.5%)  | 
| Jun 2012 | -  | $1.56M(-6.3%)  | $6.21M(-0.2%)  | 
| Mar 2012 | -  | $1.66M(+12.3%)  | $6.22M(-3.5%)  | 
| Dec 2011 | $7.61M(+17.8%)  | $1.48M(-2.7%)  | $6.45M(-9.0%)  | 
| Sep 2011 | -  | $1.52M(-3.1%)  | $7.09M(-0.8%)  | 
| Jun 2011 | -  | $1.57M(-16.8%)  | $7.15M(+0.2%)  | 
| Mar 2011 | -  | $1.88M(-11.0%)  | $7.13M(+1.0%)  | 
| Dec 2010 | $6.46M(-37.2%)  | $2.12M(+34.2%)  | $7.06M(+42.8%)  | 
| Sep 2010 | -  | $1.58M(+1.7%)  | $4.94M(-7.8%)  | 
| Jun 2010 | -  | $1.55M(-14.4%)  | $5.36M(-17.2%)  | 
| Mar 2010 | -  | $1.81M(>+9900.0%)  | $6.47M(-15.4%)  | 
| Dec 2009 | $10.28M(-13.0%)  | $0.00(-100.0%)  | $7.64M(0.0%)  | 
| Sep 2009 | -  | $1.99M(-25.1%)  | $7.64M(-6.4%)  | 
| Jun 2009 | -  | $2.66M(-10.9%)  | $8.17M(-6.0%)  | 
| Mar 2009 | -  | $2.99M(>+9900.0%)  | $8.69M(-3.1%)  | 
| Dec 2008 | $11.82M(-3.7%)  | $0.00(-100.0%)  | $8.97M(0.0%)  | 
| Sep 2008 | -  | $2.52M(-20.9%)  | $8.97M(-4.5%)  | 
| Jun 2008 | -  | $3.18M(-2.6%)  | $9.39M(+0.2%)  | 
| Mar 2008 | -  | $3.27M(>+9900.0%)  | $9.37M(+1.3%)  | 
| Dec 2007 | $12.27M(+8.1%)  | $0.00(-100.0%)  | $9.26M(-21.5%)  | 
| Sep 2007 | -  | $2.94M(-7.0%)  | $11.79M(+5.1%)  | 
| Jun 2007 | -  | $3.16M(+0.3%)  | $11.21M(+8.4%)  | 
| Mar 2007 | -  | $3.15M(+24.3%)  | $10.35M(+9.2%)  | 
| Dec 2006 | $11.35M(-28.7%)  | $2.54M(+7.3%)  | $9.48M(-1.5%)  | 
| Sep 2006 | -  | $2.36M(+3.0%)  | $9.62M(-2.0%)  | 
| Jun 2006 | -  | $2.30M(+0.5%)  | $9.82M(-1.5%)  | 
| Mar 2006 | -  | $2.28M(-14.7%)  | $9.97M(+2.8%)  | 
| Dec 2005 | $15.91M(+119.6%)  | $2.68M(+4.6%)  | $9.69M(+5.6%)  | 
| Sep 2005 | -  | $2.56M(+4.7%)  | $9.18M(+6.7%)  | 
| Jun 2005 | -  | $2.45M(+21.7%)  | $8.60M(+12.4%)  | 
| Mar 2005 | -  | $2.01M(-7.1%)  | $7.65M(+5.6%)  | 
| Dec 2004 | $7.25M(+73.2%)  | $2.16M(+9.3%)  | $7.25M(+42.6%)  | 
| Sep 2004 | -  | $1.98M(+32.5%)  | $5.08M(+35.7%)  | 
| Jun 2004 | -  | $1.49M(-7.0%)  | $3.74M(+29.4%)  | 
| Mar 2004 | -  | $1.61M(>+9900.0%)  | $2.89M(+28.1%)  | 
| Dec 2003 | $4.18M(+5.1%)  | $0.00(-100.0%)  | $2.26M(0.0%)  | 
| Sep 2003 | -  | $642.50K(-0.2%)  | $2.26M(+39.8%)  | 
| Jun 2003 | -  | $643.60K(-33.7%)  | $1.61M(+66.3%)  | 
| Mar 2003 | -  | $971.20K  | $971.20K  | 
| Dec 2002 | $3.98M(+6.0%)  | -  | -  | 
| Dec 2001 | $3.76M(+25.2%)  | -  | -  | 
| Dec 2000 | $3.00M  | -  | -  | 
FAQ
- What is ACADIA Pharmaceuticals Inc. annual SG&A?
 - What is the all-time high annual SG&A for ACADIA Pharmaceuticals Inc.?
 - What is ACADIA Pharmaceuticals Inc. annual SG&A year-on-year change?
 - What is ACADIA Pharmaceuticals Inc. quarterly SG&A?
 - What is the all-time high quarterly SG&A for ACADIA Pharmaceuticals Inc.?
 - What is ACADIA Pharmaceuticals Inc. quarterly SG&A year-on-year change?
 - What is ACADIA Pharmaceuticals Inc. TTM SG&A?
 - What is the all-time high TTM SG&A for ACADIA Pharmaceuticals Inc.?
 - What is ACADIA Pharmaceuticals Inc. TTM SG&A year-on-year change?
 
What is ACADIA Pharmaceuticals Inc. annual SG&A?
The current annual SG&A of ACAD is $488.43M
What is the all-time high annual SG&A for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual SG&A is $488.43M
What is ACADIA Pharmaceuticals Inc. annual SG&A year-on-year change?
Over the past year, ACAD annual SG&A has changed by +$81.87M (+20.14%)
What is ACADIA Pharmaceuticals Inc. quarterly SG&A?
The current quarterly SG&A of ACAD is $0.00
What is the all-time high quarterly SG&A for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly SG&A is $133.29M
What is ACADIA Pharmaceuticals Inc. quarterly SG&A year-on-year change?
Over the past year, ACAD quarterly SG&A has changed by -$117.06M (-100.00%)
What is ACADIA Pharmaceuticals Inc. TTM SG&A?
The current TTM SG&A of ACAD is -$8.90B
What is the all-time high TTM SG&A for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high TTM SG&A is -$68.37M
What is ACADIA Pharmaceuticals Inc. TTM SG&A year-on-year change?
Over the past year, ACAD TTM SG&A has changed by -$9.33B (-2147.99%)